We will continue to monitor this litigation, the shortage status of GLP-1 medications, and the impact on the industry
Clinical outcomes from the PARAMEDIC2 trial are summarized, showing higher rates of ROSC in the epinephrine group (36.3%) compared with placebo (11.7%), a modest increase in 30-day survival, but a higher proportion of survivors with severe neurological impairment (31.0% vs
Esposito, Feasibility of simplification from a basal-bolus insulin regimen to a fixed-ratio formulation of basal insulin plus a GLP-1RA or to basal insulin plus an SGLT2 inhibitor: BEYOND, a randomized, pragmatic trial
Once opened, keep at room temperature (below 86F) for up to 56 days
Clinical studies have shown that Tirzepatide can significantly reduce body weight, often outperforming traditional weight management medications
Convenient In-Clinic Blood Tests and Lab Services We strive to make your lab testing experience as straightforward as possible